The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Therapeutic Radioisotopes Market Research Report 2025
Synopsis
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The global Therapeutic Radioisotopes market was valued at US$ 1771 million in 2023 and is anticipated to reach US$ 4734 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Radioisotopes.
Report Scope
The Therapeutic Radioisotopes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Radioisotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Radioisotopes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The global Therapeutic Radioisotopes market was valued at US$ 1771 million in 2023 and is anticipated to reach US$ 4734 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Radioisotopes.
Report Scope
The Therapeutic Radioisotopes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Radioisotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Radioisotopes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Therapeutic Radioisotopes Market Overview
1.1 Product Overview and Scope of Therapeutic Radioisotopes
1.2 Therapeutic Radioisotopes Segment by Type
1.2.1 Global Therapeutic Radioisotopes Market Value Comparison by Type (2024-2030)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Therapeutic Radioisotopes Segment by Application
1.3.1 Global Therapeutic Radioisotopes Market Value by Application: (2024-2030)
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Radioisotopes Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Radioisotopes Revenue 2019-2030
1.4.2 Global Therapeutic Radioisotopes Sales 2019-2030
1.4.3 Global Therapeutic Radioisotopes Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Therapeutic Radioisotopes Market Competition by Manufacturers
2.1 Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2019-2024)
2.2 Global Therapeutic Radioisotopes Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Therapeutic Radioisotopes Average Price by Manufacturers (2019-2024)
2.4 Global Therapeutic Radioisotopes Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic Radioisotopes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic Radioisotopes, Product Type & Application
2.7 Therapeutic Radioisotopes Market Competitive Situation and Trends
2.7.1 Therapeutic Radioisotopes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Therapeutic Radioisotopes Players Market Share by Revenue
2.7.3 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic Radioisotopes Retrospective Market Scenario by Region
3.1 Global Therapeutic Radioisotopes Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Therapeutic Radioisotopes Global Therapeutic Radioisotopes Sales by Region: 2019-2030
3.2.1 Global Therapeutic Radioisotopes Sales by Region: 2019-2024
3.2.2 Global Therapeutic Radioisotopes Sales by Region: 2025-2030
3.3 Global Therapeutic Radioisotopes Global Therapeutic Radioisotopes Revenue by Region: 2019-2030
3.3.1 Global Therapeutic Radioisotopes Revenue by Region: 2019-2024
3.3.2 Global Therapeutic Radioisotopes Revenue by Region: 2025-2030
3.4 North America Therapeutic Radioisotopes Market Facts & Figures by Country
3.4.1 North America Therapeutic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Therapeutic Radioisotopes Sales by Country (2019-2030)
3.4.3 North America Therapeutic Radioisotopes Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Therapeutic Radioisotopes Market Facts & Figures by Country
3.5.1 Europe Therapeutic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Therapeutic Radioisotopes Sales by Country (2019-2030)
3.5.3 Europe Therapeutic Radioisotopes Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Radioisotopes Market Facts & Figures by Country
3.6.1 Asia Pacific Therapeutic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Therapeutic Radioisotopes Sales by Country (2019-2030)
3.6.3 Asia Pacific Therapeutic Radioisotopes Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Therapeutic Radioisotopes Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Therapeutic Radioisotopes Sales by Country (2019-2030)
3.7.3 Latin America Therapeutic Radioisotopes Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic Radioisotopes Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Therapeutic Radioisotopes Sales by Country (2019-2030)
3.8.3 Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Therapeutic Radioisotopes Sales by Type (2019-2030)
4.1.1 Global Therapeutic Radioisotopes Sales by Type (2019-2024)
4.1.2 Global Therapeutic Radioisotopes Sales by Type (2025-2030)
4.1.3 Global Therapeutic Radioisotopes Sales Market Share by Type (2019-2030)
4.2 Global Therapeutic Radioisotopes Revenue by Type (2019-2030)
4.2.1 Global Therapeutic Radioisotopes Revenue by Type (2019-2024)
4.2.2 Global Therapeutic Radioisotopes Revenue by Type (2025-2030)
4.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Type (2019-2030)
4.3 Global Therapeutic Radioisotopes Price by Type (2019-2030)
5 Segment by Application
5.1 Global Therapeutic Radioisotopes Sales by Application (2019-2030)
5.1.1 Global Therapeutic Radioisotopes Sales by Application (2019-2024)
5.1.2 Global Therapeutic Radioisotopes Sales by Application (2025-2030)
5.1.3 Global Therapeutic Radioisotopes Sales Market Share by Application (2019-2030)
5.2 Global Therapeutic Radioisotopes Revenue by Application (2019-2030)
5.2.1 Global Therapeutic Radioisotopes Revenue by Application (2019-2024)
5.2.2 Global Therapeutic Radioisotopes Revenue by Application (2025-2030)
5.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Application (2019-2030)
5.3 Global Therapeutic Radioisotopes Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Therapeutic Radioisotopes Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Therapeutic Radioisotopes Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 China Isotope & Radiation
6.3.1 China Isotope & Radiation Corporation Information
6.3.2 China Isotope & Radiation Description and Business Overview
6.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.3.4 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio
6.3.5 China Isotope & Radiation Recent Developments/Updates
6.4 Dongcheng
6.4.1 Dongcheng Corporation Information
6.4.2 Dongcheng Description and Business Overview
6.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dongcheng Therapeutic Radioisotopes Product Portfolio
6.4.5 Dongcheng Recent Developments/Updates
6.5 Q BioMed
6.5.1 Q BioMed Corporation Information
6.5.2 Q BioMed Description and Business Overview
6.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Q BioMed Therapeutic Radioisotopes Product Portfolio
6.5.5 Q BioMed Recent Developments/Updates
6.6 Curium Pharmaceuticals
6.6.1 Curium Pharmaceuticals Corporation Information
6.6.2 Curium Pharmaceuticals Description and Business Overview
6.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio
6.6.5 Curium Pharmaceuticals Recent Developments/Updates
6.7 Jubilant Radiopharma
6.6.1 Jubilant Radiopharma Corporation Information
6.6.2 Jubilant Radiopharma Description and Business Overview
6.6.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio
6.7.5 Jubilant Radiopharma Recent Developments/Updates
6.8 Lantheus
6.8.1 Lantheus Corporation Information
6.8.2 Lantheus Description and Business Overview
6.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lantheus Therapeutic Radioisotopes Product Portfolio
6.8.5 Lantheus Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporation Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 International Isotopes
6.10.1 International Isotopes Corporation Information
6.10.2 International Isotopes Description and Business Overview
6.10.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.10.4 International Isotopes Therapeutic Radioisotopes Product Portfolio
6.10.5 International Isotopes Recent Developments/Updates
6.11 Mundipharma
6.11.1 Mundipharma Corporation Information
6.11.2 Mundipharma Therapeutic Radioisotopes Description and Business Overview
6.11.3 Mundipharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mundipharma Therapeutic Radioisotopes Product Portfolio
6.11.5 Mundipharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Radioisotopes Industry Chain Analysis
7.2 Therapeutic Radioisotopes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Radioisotopes Production Mode & Process
7.4 Therapeutic Radioisotopes Sales and Marketing
7.4.1 Therapeutic Radioisotopes Sales Channels
7.4.2 Therapeutic Radioisotopes Distributors
7.5 Therapeutic Radioisotopes Customers
8 Therapeutic Radioisotopes Market Dynamics
8.1 Therapeutic Radioisotopes Industry Trends
8.2 Therapeutic Radioisotopes Market Drivers
8.3 Therapeutic Radioisotopes Market Challenges
8.4 Therapeutic Radioisotopes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
